A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet

Clinical trial NCT01430091 · COMPLETED

Trial details

NCT number: NCT01430091
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2011-09-01
Primary completion: 2011-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.